Detalhe da pesquisa
1.
CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.
Immunity
; 49(3): 464-476.e4, 2018 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30193847
2.
The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma.
Cancer Immunol Immunother
; 67(4): 615-626, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327110
3.
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model.
Blood Adv
; 8(4): 947-958, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181781
4.
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
Cancers (Basel)
; 15(5)2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900230
5.
Direct observation of space charge induced hydrogen ion insertion in nanoscale anatase TiO2.
Chem Commun (Camb)
; (47): 6342-4, 2008 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19048149